Financial Consulate’s Clearside Biomedical CLSD Stock Holding History

Financial Consulate’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-66	Closed	-$263	–	1364
2025 Q3	$263	Buy	+66	New	+$450	﹤0.01%	1123

Other funds holding CLSD

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Financial Consulate's CLSD Position: Q4 2025 in Review

Financial Consulate sold out of Clearside Biomedical (CLSD) in Q4 2025, closing a stake of 66 shares — an estimated $263 sold.

Financial Consulate first reported a position in CLSD in Q3 2025 and held it in 1 quarter. The position peaked at $263 in Q3 2025. 1 fund tracked by Wall St. Rank holds CLSD as of Q4 2025.

Financial Consulate reported no remaining Clearside Biomedical position as of Q4 2025 after selling out during the quarter.
Financial Consulate sold 66 Clearside Biomedical shares in Q4 2025, an estimated $263.
Financial Consulate first reported a position in Clearside Biomedical in Q3 2025 and held it in 1 quarter.
Financial Consulate's Clearside Biomedical position peaked at $263 in Q3 2025.
1 fund tracked by Wall St. Rank held Clearside Biomedical as of Q4 2025.

Based on Financial Consulate's 13F filing for Q4 2025, filed 22 Jan 2026.